• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3

CATEGORIES

  • 3
  • 2
  • 2
  • 1

PRICE

0
1
5
8

PUBLISHED

0
0
2
8

PRODUCT TYPE

8

Search "MAT Biopharma-Therapeutic Competitors Report" returned 8 results.

Competitor Analysis - Cancer Antibodies in Early Clinical Development Competitor Analysis - Cancer Antibodies in Early Clinical Development - Product Thumbnail Image

Competitor Analysis - Cancer Antibodies in Early Clinical Development

The present Competitive Intelligence Report about Cancer Antibodies in Early Clinical Development provides a competitor evaluation in the field of antibody therapeutics being developed for treatment...

February 2011
FROM

High Triglyceridemia - Pipeline Review, H2 2014

High Triglyceridemia - Pipeline Review, H2 2014 Summary This, ‘High Triglyceridemia - Pipeline Review, H2 2014’, provides an overview of the High Triglyceridemia’s therapeutic pipeline. This report...

October 2014
FROM

Mixed Dyslipidemia - Pipeline Review, H1 2014

Mixed Dyslipidemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mixed Dyslipidemia - Pipeline Review, H1 2014’, provides an overview of the Mixed Dyslipidemia’s therapeutic pipeline. This...

May 2014
FROM

Dyslipidemia - Pipeline Review, H1 2014

Dyslipidemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2014’, provides an overview of the Dyslipidemia’s therapeutic pipeline. This report provides...

February 2014
FROM

Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing angiogenesis affecting drug development in cancer Find out whether you are number one, two or further...

January 2012

High Triglyceridemia - Pipeline Review, H1 2015

High Triglyceridemia - Pipeline Review, H1 2015 Summary This, ‘High Triglyceridemia - Pipeline Review, H1 2015’, provides an overview of the High Triglyceridemia’s therapeutic pipeline. This report...

January 2015
FROM

A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 313 leukemia drugs within the portfolio of 186 companies, from Ceased to Marketed. The report extensively analyses their 204 identified...

April 2011
FROM

The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in one of the fastest growing segments in the pharmaceutical market, namely antibodies for the treatment of cancer...

September 2011
FROM
Loading Indicator

Our Clients

Hewlett-Packard Company Microsoft Corporation Philips N.V. SONY Corporation Cypress Semiconductor Corporation Panasonic Corporation